🇺🇸 Gadoteric Acid Meglumine Salt in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Adrenomegaly — 1 report (10%)
  2. Ascites — 1 report (10%)
  3. Diarrhoea — 1 report (10%)
  4. Granulocytopenia — 1 report (10%)
  5. Hepatic Cyst — 1 report (10%)
  6. Neoplasm Progression — 1 report (10%)
  7. Oedema Peripheral — 1 report (10%)
  8. Pneumonia — 1 report (10%)
  9. Pneumonitis — 1 report (10%)
  10. Renal Cyst — 1 report (10%)

Source database →

Other Diagnostic Imaging approved in United States

Frequently asked questions

Is Gadoteric Acid Meglumine Salt approved in United States?

Gadoteric Acid Meglumine Salt does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Gadoteric Acid Meglumine Salt in United States?

The Central Hospital of Lishui City is the originator. The local marketing authorisation holder may differ — check the official source linked above.